Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Oklahoma Health Sciences Center

University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma, United States is listed as a site for 1,208 registered clinical trials, 505 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,208
Ongoing 505

This page covers the site record University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the University of Oklahoma Health Sciences Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,208 trials counted.

  • Phase 1 86 trials
  • Phase 1/2 50 trials
  • Phase 2 416 trials
  • Phase 2/3 53 trials
  • Phase 3 383 trials
  • Phase 4 15 trials
  • Not applicable 108 trials
  • Observational 94 trials
  • Expanded access 2 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 505 trials
  • Completed 565 trials
  • Terminated 107 trials
  • Other 31 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access, Unknown)

Top of scale: 71

1992: 2 trials (Observational 1, Not applicable 1) 1994: 2 trials (Phase 3 1, Phase 2 1) 1996: 1 trials (Phase 3 1) 1997: 3 trials (Observational 1, Phase 3 1, Phase 1 1) 1998: 7 trials (Phase 3 3, Phase 2 2, Phase 1/2 1, Phase 1 1) 1999: 4 trials (Observational 2, Phase 1/2 1, Phase 1 1) 2000: 14 trials (Observational 1, Phase 3 5, Phase 2/3 2, Phase 2 6) 2001: 15 trials (Not applicable 1, Phase 3 2, Phase 2 9, Phase 1/2 3) 2002: 7 trials (Phase 3 4, Phase 2 3) 2003: 12 trials (Observational 2, Phase 3 7, Phase 2 3) 2004: 14 trials (Observational 3, Not applicable 2, Phase 3 6, Phase 2 1, Phase 1 2) 2005: 25 trials (Observational 4, Not applicable 1, Phase 4 1, Phase 3 6, Phase 2 7, Phase 1/2 1, Phase 1 5) 2006: 32 trials (Observational 4, Not applicable 4, Phase 4 1, Phase 3 12, Phase 2 9, Phase 1/2 1, Phase 1 1) 2007: 34 trials (Other 1, Observational 4, Not applicable 2, Phase 4 1, Phase 3 12, Phase 2/3 1, Phase 2 11, Phase 1/2 1, Phase 1 1) 2008: 37 trials (Observational 6, Not applicable 5, Phase 4 1, Phase 3 11, Phase 2/3 1, Phase 2 8, Phase 1/2 2, Phase 1 3) 2009: 58 trials (Other 1, Observational 10, Not applicable 5, Phase 4 1, Phase 3 25, Phase 2 14, Phase 1/2 1, Phase 1 1) 2010: 50 trials (Observational 8, Not applicable 2, Phase 3 13, Phase 2 24, Phase 1 3) 2011: 53 trials (Observational 10, Not applicable 2, Phase 4 1, Phase 3 15, Phase 2/3 1, Phase 2 18, Phase 1/2 1, Phase 1 5) 2012: 54 trials (Observational 6, Not applicable 2, Phase 3 10, Phase 2/3 1, Phase 2 27, Phase 1/2 5, Phase 1 3) 2013: 41 trials (Observational 2, Not applicable 4, Phase 4 1, Phase 3 14, Phase 2/3 1, Phase 2 14, Phase 1/2 1, Phase 1 4) 2014: 56 trials (Observational 6, Not applicable 5, Phase 3 17, Phase 2/3 10, Phase 2 13, Phase 1/2 4, Phase 1 1) 2015: 54 trials (Observational 5, Not applicable 3, Phase 4 3, Phase 3 19, Phase 2/3 4, Phase 2 18, Phase 1/2 1, Phase 1 1) 2016: 34 trials (Observational 1, Not applicable 5, Phase 3 9, Phase 2/3 1, Phase 2 14, Phase 1/2 3, Phase 1 1) 2017: 68 trials (Observational 5, Not applicable 6, Phase 3 22, Phase 2/3 2, Phase 2 26, Phase 1/2 1, Phase 1 6) 2018: 63 trials (Observational 1, Not applicable 7, Phase 3 21, Phase 2/3 2, Phase 2 26, Phase 1/2 1, Phase 1 5) 2019: 69 trials (Observational 2, Not applicable 4, Phase 3 26, Phase 2/3 5, Phase 2 25, Phase 1/2 2, Phase 1 5) 2020: 68 trials (Observational 7, Not applicable 7, Phase 4 1, Phase 3 20, Phase 2/3 3, Phase 2 25, Phase 1/2 1, Phase 1 4) 2021: 67 trials (Observational 1, Not applicable 9, Phase 4 1, Phase 3 20, Phase 2/3 3, Phase 2 21, Phase 1/2 4, Phase 1 8) 2022: 64 trials (Observational 1, Not applicable 13, Phase 3 17, Phase 2/3 6, Phase 2 18, Phase 1/2 4, Phase 1 5) 2023: 71 trials (Observational 1, Not applicable 5, Phase 4 2, Phase 3 21, Phase 2/3 4, Phase 2 24, Phase 1/2 6, Phase 1 8) 2024: 52 trials (Not applicable 5, Phase 3 11, Phase 2/3 4, Phase 2 25, Phase 1 7) 2025: 49 trials (Not applicable 3, Phase 4 1, Phase 3 24, Phase 2/3 2, Phase 2 13, Phase 1/2 4, Phase 1 2)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 23
2025 49
2024 52
2023 71
2022 64
2021 67
2020 68
2019 69
2018 63
2017 68

Showing 10 of 33 years.

Start your 14-day trial Email me all 33 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,208 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 136 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 428 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF